Ledipasvir (D-tartrate)

Ledipasvir (D-tartrate) Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:Ledipasvir D-tartrate;GS-5885 D-tartrate
CAS:1502654-87-6
Purity:98.00% Package:10 mg;100 mg;2 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105
Email: sales@invivochem.cn
Products Intro: Product Name:Ledipasvir D-tartrate
CAS:1502654-87-6
Purity:98% Package:5mg Remarks:V3508
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:Ledipasvir D-tartrate
CAS:1502654-87-6
Purity:98% Package:$66.9/2mg;$84.9/5mg;$108.9/10mg;$300.9/50mg;$540.9/100mg;Bulk package Remarks:98%
Company Name: Haoyuan Chemexpress Co., Ltd.  
Tel: 021-58950125
Email: info@chemexpress.com
Products Intro: Product Name:Ledipasvir (D-tartrate)
CAS:1502654-87-6
Purity:>98% Package:800RMB/2mg
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185
Email: sales-cpd@caerulumpharma.com
Products Intro: Product Name:Ledipasvir D-tartrate
CAS:1502654-87-6
Purity:98% Package:1g;10g;100g
Ledipasvir (D-tartrate) Basic information
Product Name:Ledipasvir (D-tartrate)
Synonyms:GS 5885 D-tartrate;GS5885 D-tartrate);HY-15602B (GS-5885 D-tartrate
CAS:1502654-87-6
MF:C53H60F2N8O12
MW:1039.1
EINECS:
Product Categories:
Mol File:1502654-87-6.mol
Ledipasvir (D-tartrate) Structure
Ledipasvir (D-tartrate) Chemical Properties
storage temp. Store at -20°C
solubility DMSO: ≥ 28 mg/mL (26.95 mM)
form Powder
Safety Information
MSDS Information
Ledipasvir (D-tartrate) Usage And Synthesis
DescriptionLedipasvir D-tartrate is an inhibitor of the hepatitis C virus NS5A, with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon.
in vitroIn Vitro:Ledipasvir has GT1a and 1b EC50 values of 31 and 4 pM, respectively, and protein-adjusted EC50 values of 210 pM (GT1a) and 27 pM (GT1b) and the intrinsic EC50 of 39 is 310 fM for GT1a and 40 fM for GT1b. Ledipasvir is highly protein-bound both in human serum and in the cell-culture medium (containing 10% BSA) of the replicon assay[1]. Ledipasvir exhibits an EC50 value of 141 nM against the JFH/3a-NS5A replicon[2].
in vivoIn Vivo:Ledipasvir is remarkable not only on the basis of its high replicon potency but also on the basis of its low clearance, good bioavailability, and long half-lives in rat, dog, and monkey and low predicted clearance in human. The pharmacokinetics of Ledipasvir is measured in rats and dogs. Ledipasvir shows good half-lives (rat 1.83 ± 0.22 hr, dog 2.63 ± 0.18 hr) in plasma, low systemic clearance (CL), and moderate volumes of distribution (Vss) that are greater than total body water volume[1].
ReferencesReferences:[1]. Link JO, et al. Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection. J Med Chem. 2014 Mar 13;57(5):2033-46. [2]. Hernandez D, et al. Natural prevalence of NS5A polymorphisms in subjects infected with hepatitis C virus genotype 3 and their effects on the antiviral activity of NS5A inhibitors. J Clin Virol. 2013 May;57(1):13-8.
Ledipasvir (D-tartrate) Preparation Products And Raw materials
Tag:Ledipasvir (D-tartrate)(1502654-87-6) Related Product Information